As mentioned earlier, AMPK acts as a positive regulator of PGC-1α, and pharmacological activation of AMPK followed by restoration of PGC-1α expression has shown promising results in alleviating DKD [607]. This evidence concerns the gene PPARGC1A and diabetic kidney disease.